Page 10 - Wei Yan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CPEC Industrial Cooperation Textile B2B Webinar Highlights Areas for Cooperation in Textile In a bid to promote business alliances and sectoral matchmaking between private enterprises of the textile sector of Pakistan & China, the Prime Minister’s Office, Board of Investment, Pakistan, organized a “CPEC Industrial Cooperation Textile Business to Business (B2B) Webinar” in collaboration with China Council for International Investment Promotion (CCIIP) and China National Textile & Apparel Council (CNTAC). The webinar offered a platform for analysis of industry trends, bilateral investment...

Share this article Share this article BOTHELL, Wash., April 13, 2021 /PRNewswire/ -- Qilu Puget Sound Biotherapeutic Corp. (Sound Biologics), an emerging biotechnology company focused on developing a novel MabPair ™ platform for antibody-based combination therapies for the treatment of cancer, inflammation and autoimmune disease, announced a clinical update on its first MabPair product PSB205 at the American Association for Cancer Research (AACR) Annual Meeting. Dr Li Zhang of Sun Yat-Sen University Cancer Centre (SYSUCC), Guangzhou, China presented a poster on Phase 1 Clinical Trial result...

2021-04-07 13:05:36 GMT2021-04-07 21:05:36(Beijing Time) Xinhua English NANNING, April 7 (Xinhua) -- The 18th China-ASEAN Expo will take place both online and offline in Nanning, capital of south China's Guangxi Zhuang Autonomous Region, in September, the organizer said on Wednesday. This year marks the 30th anniversary of dialogue relations between China and the Association of Southeast Asian Nations (ASEAN). This year's expo will help expand the platform functions of the expo. It will also further serve the construction of the Belt and Road Initiative and the Regional Comprehensive E...

In a new paper published by Nature Communications, The Lundquist Institute (TLI) Investigator Wei Yan, MD, PhD, and his research colleagues spell out an innovative strategy that has led to the discovery of a natural compound as a safe, effective and reversible male contraceptive agent in pre-clinical animal models

In a new paper published by Nature Communications, The Lundquist Institute (TLI) Investigator Wei Yan, MD, PhD, and his research colleagues spell out an innovative strategy that has led to the discovery of a natural compound as a safe, effective and reversible male contraceptive agent in pre-clinical animal models. Despite tremendous efforts over the past decades, the progress in developing non-hormonal male contraceptives has been very limited.